dr. flinn on the fda approval of duvelisib in cll and follicular lymphoma
Published 5 years ago • 287 plays • Length 1:06Download video MP4
Download video MP3
Similar videos
-
1:31
dr. leslie discusses duvelisib in follicular lymphoma
-
0:39
dr. flinn on fda approval of tisagenlecleucel in dlbcl
-
0:27
copy of dr. flinn on the relevance trial in follicular lymphoma
-
11:13
fda approval in cll and fl, partial hold lifted in tazmetostat trials, and more
-
1:30
dr. flinn on the relevance trial in follicular lymphoma
-
1:06
dr nowakowski on the fda approval of epcoritamab in r/r follicular lymphoma
-
0:57
dr. flinn on fda approval of frontline brentuximab vedotin with avd in hodgkin lymphoma
-
0:54
dr. ian flinn on the changing treatment paradigm for cll and low-grade lymphoma
-
0:57
dr. grossbard on the dynamo study with duvelisib in follicular lymphoma
-
1:16
dr. flinn on the utility of tafasitamab in relapsed/refractory dlbcl
-
5:45
follicular lymphoma: optimizing novel agent therapy
-
0:51
dr. casulo on predicting outcomes in follicular lymphoma
-
1:24
dr. flinn on car t-cell therapy in non-hodgkin lymphoma
-
1:05
dr. ian flinn discusses the efficacy of ipi-145 in cll
-
1:16
dr. lacasce discusses the fda approval of lenalidomide/rituximab in non-hodgkin lymphoma
-
1:09
dr. flinn on opportunities for second-line tafasitamab in dlbcl
-
1:19
a study of duvelisib vs ofatumumab in relapsed/refractory cll
-
0:54
dr. flinn discusses the dynamo trial
-
2:07
dr. ferrajoli on the fda approval of ibrutinib in cll